SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AstraZeneca Investors May Focus on Next-Year Outlook After Q3 Results

Bank of America analysts say investors might shift focus to AstraZeneca’s outlook for next year after the company reported better-than-expected third-quarter results and left full-year guidance unchanged.

AZN

Story updates

12:44:14 PM UTC
SquawkNews
AstraZeneca's Investments Prevent Guidance Raise — Market Talk

Related stories